The median toxic dose (TD 50 ) of type C botulinurn in turkeys was determined using an up-anddown method for toxicologic testing. Birds were dosed intravenously with 10, 20, or 40 mouse lethal dose per kilogram body weight (MLD/kg) of type C botulism toxin and observed for 5 days. Administration of toxin resulted in acute death, posterior paresis, or no effect, depending upon the dose. The TD 50 causing posterior paresis was calculated as 25.75 MLD/kg (confidence interval = 17.08-38.82 MLD/kg). Posterior paresis was identified as the principal sign associated with sublethal botulism toxicosis in turkeys. The resultant posterior paresis was similar to the clinical syndrome observed in an unsolved field investigation.
test bird was given the next higher geometric level dose according to the formula D n = D 1 x p ( n-1 ) , where D is the dose administered, n is the subject number (1-7) and p is a constant, 3,4 until a dose was reached that caused posterior paresis. Conversely, if posterior paresis developed, the succeeding test bird was given the next lower geometric level dose. This up-and-down dosing was repeated until 3 reversals between positive clinical signs and no clinical signs were observed. The TD 50 was calculated using the trimmed logit method. 18 Toxin. Type C botulism toxin in a sterile buffer solution a was titrated at 10 5.5 MLD 50 /ml using the mouse neutralization technique. 9 The toxin was split and frozen in 200-µl aliquots at -70 C. Each experimental dose was calculated based on the weight of the turkey in kilograms, and the toxin was thawed and diluted in 1 ml of sterile phosphate-buffered saline immediately prior to intravenous administration.
Experimental subjects. One turkey b was used for a single observation. Each turkey was weighed on arrival (Table 1) and examined for gross leg deformity, swollen joints, and general health. A tracheal swab was obtained for mycoplasma culture, and a blood sample was collected. Birds were housed in an isolation room and provided with feed and water ad libitum. Toxin was injected into the brachial vein. Birds were necropsied when signs developed or on day 5. Joints and bones were examined for the presence of osteomyelitis, tibia1 dyschondroplasia, or tenosynovitis.
Histopathology. Tissues submitted for histologic examination in all cases included sciatic nerve, gracilis muscle (medial thigh), lung, and brain. Tracheas were examined in 2 cases. Tissues were fixed in 10% formalin, trimmed, embedded in paraffin, sectioned at 5 µm, and stained with hematoxylin and eosin.
Bacteriology. Tracheas were cultured for mycoplasma by tracheal swab at injection (day 1) and at necropsy on a modified Frey's broth and agar medium and incubated in 5% carbon dioxide and 98% humidity at 37 C for 21 days. 5, 10 Serology. Serum was tested for antibodies to Mycoplasma synoviae (MS) using the serum-plate agglutination test c and to Newcastle disease virus using an enzyme-linked immunosorbent assay (ELISA). d
Results
Four turkeys dosed at 10 and 20 MLD/kg remained weight bearing or developed no signs and were considered negative for posterior paresis. Three birds given 40 MLD/kg were not weight bearing and were considered positive for posterior paresis ( Table 2) . Turkeys that became paretic generally developed clinical signs between 24 and 48 hours postinjection. Three reversals from negative to positive clinical signs were demonstrated at these doses (Fig. 1) . The TD 50 for type C botulism toxin was calculated as 25.75 MLD/kg (confidence interval = 17.08-38.82 MLD/kg). 18 One bird, found dead, had an enlarged spleen and mild gassy distention of the duodenum, which were considered terminal or postmortem changes. Otherwise, no significant gross lesions were identified at necropsy in any birds.
Histologic muscle changes were found in both positive (2/3) and negative (2/4) turkeys. There was mild multifocal shrinkage of individual myofibers (< 10% to 25% per section) and mild hypereosinophilia with rare loss of striations. Four of 7 birds (l/3 positive and 3/4 negative) also had respiratory tract lesions consisting of mild tracheal mucosal gland hyperplasia, mild to moderate lymphocytic peribronchiolar infiltrates, and mild multifocal granulomatous pneumonia with fungal hyphae. No histologic lesions were identified in brains or sciatic nerves. Serologic titers for Newcastle disease were moderate (ELISA group 5-8) in all birds. Mycoplasma cultures and MS serology were negative. of botulism toxin have been reported to result in progressive posterior to anterior paralysis followed by an anterior to posterior recovery in gallinaceous birds, including turkeys. 8, 9, 11 Symptoms appeared within a few hours to 1-2 days after ingestion of toxin. Recovery from paralysis after 2-3 days has been described if water and feed are made readily available. 6, 7, 13, 15, 20 Necropsy findings in cases of type C botulism are uniformly unremarkable, with no gross or microscopic lesions reported. 2, 17 These reports are in accordance with signs observed in the field investigation 14 and also concur with the clinical appearance of turkeys administered type C botulism toxin in this experiment. In the field investigation, the high mortality in the flock probably reflected the effects of heat, crowding, dehydration, and competition on paralytic turkeys, rather than ingestion of a lethal dose of toxin. 14 Botulinum toxins exert their pharmacologic effect by blocking the release of acetylcholine from nerve endings. 19 The toxin has been shown to affect 4 different sites in mammals: the neuromuscular junction, the autonomic ganglia, postganglionic parasympathetic nerve endings, and postganglionic sympathetic nerve
Discussion
In general, the onset and severity of clinical signs of type C botulism in poultry is dose related. The LD 50 values for chickens, peafowl, pheasants, and turkeys have been determined by intravenous and oral inoculation. 12, 16 The LD 50 for type C1 botulism toxin in chickens via intravenous inoculation is 16,000 MLD/ kg, in the peafowl 2,700 MLD/kg, in turkeys 320 MLD/ kg, and in the pheasant 60 MLD/kg. Thus, the turkey is 50 times more sensitive to type C1 toxin than is the chicken. 12 Previous studies did not address the quantity of tox- endings that release acetylcholine. The first step in the interaction between the toxin and the cholinergic nerve ending is binding to the cell surface. The toxin is then translocated to the interior of the cell. A lytic phase in then proposed that blocks the release of acetylcholine. 19 Because this binding is irreversible, it may be feasible that a large proportion of the toxic dose is removed from the circulation and is no longer available for detection in serum or tissues. 12, 19 This also suggests a reason the mouse bioassay may not be of adequate sensitivity to diagnose sublethal botulism toxicosis in turkeys and why botulism toxin was undetected in our field investigation. Slow metabolism of the toxin may allow the slow recovery reported in the literature 12 and observed in this study and in the field outbreaks investigated. 14 Tissue differences in susceptibility to botulinurn toxins have been demonstrated. 19 The autonomic nervous system of all species has been shown to be more resistant than the alpha-motoneurons to toxins. 19 For example, the classical wasp-waist breathing in mice demonstrates the sensitivity of neuromuscular junctions of the diaphragm to the effects of botulism toxin. Higher numbers of neuromuscular junctions in voluntary skeletal muscles versus smooth muscles 1 may account for some of the differences in tissue sensitivity. In turkeys, the motoneurons of leg and wing muscles appear to be the first and most severely affected by type C botulism toxin.
In this study, administration of sublethal doses of botulism type C toxin caused posterior paresis. The syndrome experimentally produced by administration of type C toxin was similar to the posterior paresis investigated in a commercial turkey flock. 14 The paresis was produced by levels of type C toxin much lower than the reported lethal dose. 12 Samples submitted for the mouse bioassay may have contained a quantity of type Cl botulism that caused clinical signs in turkeys but exceeded the detection limits of the test, or the quantity of free unbound type C toxin in serum samples from paretic turkeys may have exceeded the detection limits of the mouse bioassay.
Serum samples collected from turkeys who developed acute posterior paresis and became completely non-weight bearing or died within 24 hours of inoculation were positive for toxin in the mouse bioassay. But samples collected from a turkey with chronic mild symptoms of leg weakness that did not become nonweight bearing until day 5 postinoculation were negative. Thus, we may be more successful in diagnosing sublethal botulism toxicosis during field investigations if blood samples are obtained from fresh dead birds with their legs extended posteriorly, indicating they died of acute toxicosis, rather than from birds with chronic mild symptoms of unknown duration.
